Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing trials last month.

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer's disease. A new study published in ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

Older adults are increasingly being diagnosed with limbic-predominant age-related TDP-43 encephalopathy (LATE) dementia. This is in part due to new guidelines advising doctors how to identify the ...

In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.

Scientists from Yale University have revealed how the brain protects itself from the toxic effects of calcium, which may hold ...

Kidney health may not raise dementia risk, but it can shift how fast dementia symptoms appear in those already vulnerable.

Diagnostic blood tests were approved, and the number of Americans with Alzheimer's kept cl ...

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs).

For years, Los Altos resident Kim Wilford watched Alzheimer’s Disease rob her beloved mother-in-law of her memories, spirit ...